Clinical Efficacy and Adverse Reactions of Bevacizumab plus Radiochemotherapy in the Treatment of Advanced Gastric Cancer

Table 2

Comparison of clinical efficacy between the two groups (n/%).

Groups	n	CR	PR	SD	PD	Total efficacy
Research group	43	3/6.98	24/55.81	3/6.98	13/30.23	30/69.77
Control group	43	1/2.33	9/20.93	7/16.28	26/60.47	17/39.53
χ^2						7.929
						0.005

CR, complete remission; PR, partial remission; SD, stable disease; PD, progressive disease.